Compounds > panipenem-betamipron
Page last updated: 2024-09-03

panipenem-betamipron and Cross Infection

panipenem-betamipron has been researched along with Cross Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, T; Kokubun, H; Matsuura, N; Nishisako, M; Nonoyama, M; Nowatari, M; Oguchi, K; Shimada, S; Sunakawa, K1

Other Studies

2 other study(ies) available for panipenem-betamipron and Cross Infection

ArticleYear
[The clinical efficacy and safety of panipenem-betamipron in treatment of moderate to severe pulmonary infection].
    Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:7

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Alanine; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Thienamycins; Treatment Outcome

2012
[Pharmacokinetics of panipenem in neonates and dosage recommendation].
    The Japanese journal of antibiotics, 2000, Volume: 53, Issue:4

    Topics: Bacterial Infections; beta-Alanine; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Half-Life; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Metabolic Clearance Rate; Models, Biological; Thienamycins

2000